Philogen

Health

Philogen enters into a Service and Supply Agreement with

Globe News Wire Jun 28, 2023

Philogen enters into a Service and Supply Agreement with IBSA for the GMP Production of a Therapeutic Protein Siena, Italy, 28th June 2023 – Philogen S.p.A (BIT: PHIL) today announced that it has entered into a Service and Supply…

Health

Philogen Announces Clinical Trial Collaboration with MSD

Globe News Wire Jun 1, 2023

The Phase II clinical trial investigates Philogen's immunocytokines (i) L19IL2 (ii) L19TNF, and (iii) Nidlegy™ in combination with MSD’s anti-PD-1 therapy, KEYTRUDA® (pembrolizumab) in stage III and IV unresectable melanoma patients who…

Health

Philogen Publishes New Data on a Fibromun-based treatment

Globe News Wire May 25, 2023

Philogen Publishes New Data on a Fibromun-based treatment…

Health

Philogen Provides Corporate Update

Globe News Wire Dec 1, 2022

Philogen Provides Corporate Update Nidlegy™ and Fibromun pivotal clinical trials on track Fibromun shows potent activity in last-line glioblastoma in combination with LomustineOncoFAP platform shows promising results in both…